Health Problems in a Large Cohort of Americans Traveling to Developing Countries
Open Access
- 8 March 2006
- journal article
- Published by Oxford University Press (OUP) in Journal of Travel Medicine
- Vol. 7 (5), 259-266
- https://doi.org/10.2310/7060.2000.00075
Abstract
Millions of Americans visit developing countries each year, however, little is known about their health during travel. This study describes health problems in a large cohort of American travelers during and after their trip. A 2‐year survey of 784 travelers (95% follow‐up) was conducted for persons traveling for ≥ 90 days. At the pretravel visit, travelers were given a postcard to record adverse health events. Following travel, standardized telephone interviews were performed for any positive responses, or if the card was not returned. All travelers were contacted 2 months after return to determine late occurring illness and compliance with antimalarials. Travelers had a mean age of 44 years, a median duration of 19 days, and visited 123 countries. An illness was reported by 64% (1.6 illnesses per traveler). Ill travelers were more often female, and traveled longer than those who were not ill; depending upon destination, each day of travel increased by 3 to 4% the chance of becoming ill. Diarrhea was most common, occurring in 46%; 34% met a strict definition for traveler's diarrhea. Respiratory illness occurred in 26%, skin disorders in 8%, acute mountain sickness in 6%, motion sickness in 5%, accidents and injuries in 5%, and isolated febrile episodes in 3%. Medical care was sought by 8% of all travelers and 12% of those reporting illness. On return, 26% of travelers were ill, 56% of whom became ill after return. Diarrhea, respiratory illness, skin disorders, and febrile syndromes were most common, and 46% of those who were ill sought medical care. Complete compliance with antimalarials was 80%. Noncompliant individuals usually discontinued medications on return. Side effects were reported by 4% of those taking chloroquine, 11% of those taking chloroquine plus proguanil, and 14% of those taking mefloquine, with half of these neuropsychiatric. The incidence of documented malaria was 3.8 cases per 1,000 travelers. Many travelers experience adverse health events during and after travel to the developing world. Attention to the prevention and therapy of traveler's diarrhea, prophylaxis of malaria, management of respiratory illness, personal safety, and access to medical care during travel, and, recognition of clinical syndromes after return, will help to improve the traveler's health.Keywords
This publication has 33 references indexed in Scilit:
- Mefloquine for Malaria Chemoprophylaxis 1992–1998: A ReviewJournal of Travel Medicine, 1999
- Effectiveness of chemoprophylaxis and other determinants of malaria in travellers to KenyaTropical Medicine & International Health, 1998
- Risk Behavior for Travelers' Diarrhea Among Finnish TravelersJournal of Travel Medicine, 1995
- Travel Illness and the Family Practitioner: A Retrospective Assessment of Travel‐Induced Illness in General Practice and the Effect of a Travel Illness ClinicJournal of Travel Medicine, 1994
- Prevention and Treatment of Traveler's DiarrheaNew England Journal of Medicine, 1993
- Overseas fatalities of United States citizen travelers: An analysis of deaths related to international travelAnnals of Emergency Medicine, 1991
- Epidemiological Surveillance in Peace Corps Volunteers: A Model for Monitoring Health in Temporary Residents of Developing CountriesInternational Journal of Epidemiology, 1989
- Health Problems After Travel to Developing CountriesThe Journal of Infectious Diseases, 1987
- Treatment of Travelers' Diarrhea with Trimethoprim/Sulfamethoxazole and with Trimethoprim AloneNew England Journal of Medicine, 1982
- TURISTA AT AN INTERNATIONAL CONGRESS IN MEXICOThe Lancet, 1973